CLCS
CELL SOURCE INC
stockOTC
EODOct 2, 2026
0.40USD-14.876%(-0.07)4,575
Loading…
Loading…
16.78M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$0.47
Beta
1.26
52-Week High
$2.25 2026-02-27
52-Week Low
$0.25 2026-08-12
SMA 50
$0.66
SMA 200
$0.64
Avg. Vol 10D
3,856
Avg. Vol 30D
4,771
Avg. Vol 90D
3,657
Relative Vol
0.96
41.94M
54.53M
1,915
0.00%
1.00
30
CLCS Profile
marrow cell source , has been started with the aim to cater to patients who required a matched bone marrow sample. indian gene pool requires a bone marrow registry
CLCS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.44 | 2026-09-28 | -8.53% | -11.119 |
| 1M | 0.52 | 2026-09-04 | -22.65% | -9.550 |
| 3M | 0.87 | 2026-07-06 | -54.26% | -1.053 |
| 6M | 0.69 | 2026-04-06 | -42.03% | 0.568 |
| 1Y | 0.35 | 2025-10-03 | +14.29% | 1.256 |
| 2Y | 0.30 | 2024-10-03 | +33.33% | — |
| 5Y | 1.51 | 2021-10-04 | -73.51% | 23.681 |
CLCS Stock Summary
CELL SOURCE INC (OTC:CLCS) stock price today is $0.40, and today's volume is 4,575. CLCS is down 14.876% today. The 30 day average volume is 4,771. CLCS market cap is $16.78M with 41.94M shares outstanding.